価格を簿価で割った値 (P/BV)
2005年以降
難易度が低い
計算
Eli Lilly & Co., P/BV, 長期的な傾向、計算
P/BV | = | 株価1, 2, 3 | ÷ | 一株当たり簿価1 (BVPS) | BVPS1 | = | Eli Lillyと会社の株主資本の合計1 (数千) |
÷ | 発行済普通株式数2 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
2019/12/31 | 51.67 | = | 140.83 | ÷ | 2.73 | 2.73 | = | 2,606,900 | ÷ | 956,382,203 | |
2018/12/31 | 12.87 | = | 122.13 | ÷ | 9.49 | 9.49 | = | 9,828,700 | ÷ | 1,035,418,562 | |
2017/12/31 | 7.33 | = | 77.55 | ÷ | 10.58 | 10.58 | = | 11,592,200 | ÷ | 1,095,597,580 | |
2016/12/31 | 6.33 | = | 80.36 | ÷ | 12.70 | 12.70 | = | 14,007,700 | ÷ | 1,103,352,450 | |
2015/12/31 | 5.51 | = | 72.61 | ÷ | 13.17 | 13.17 | = | 14,571,300 | ÷ | 1,106,093,485 | |
2014/12/31 | 5.14 | = | 71.12 | ÷ | 13.84 | 13.84 | = | 15,373,200 | ÷ | 1,111,103,942 | |
2013/12/31 | 3.69 | = | 58.09 | ÷ | 15.75 | 15.75 | = | 17,631,400 | ÷ | 1,119,713,084 | |
2012/12/31 | 4.15 | = | 54.02 | ÷ | 13.02 | 13.02 | = | 14,765,200 | ÷ | 1,134,411,762 | |
2011/12/31 | 3.35 | = | 39.05 | ÷ | 11.67 | 11.67 | = | 13,541,700 | ÷ | 1,160,406,840 | |
2010/12/31 | 3.21 | = | 34.43 | ÷ | 10.73 | 10.73 | = | 12,420,300 | ÷ | 1,157,664,779 | |
2009/12/31 | 4.17 | = | 34.47 | ÷ | 8.26 | 8.26 | = | 9,523,700 | ÷ | 1,153,145,432 | |
2008/12/31 | 5.01 | = | 29.38 | ÷ | 5.86 | 5.86 | = | 6,735,300 | ÷ | 1,149,015,882 | |
2007/12/31 | 4.16 | = | 50.02 | ÷ | 12.02 | 12.02 | = | 13,664,400 | ÷ | 1,136,985,018 | |
2006/12/31 | 5.43 | = | 52.59 | ÷ | 9.68 | 9.68 | = | 10,980,700 | ÷ | 1,134,034,234 | |
2005/12/31 | 5.85 | = | 55.89 | ÷ | 9.55 | 9.55 | = | 10,791,900 | ÷ | 1,129,982,580 |
ソース: Eli Lilly & Co. (NYSE:LLY) | P/BV since 2005 (www.stock-analysis-on.net)
1 米ドル$
2 分割および株式配当について調整されたデータ。
3 Eli Lilly&Co.の年次報告書の提出日における終値
競合他社との比較
Eli Lilly & Co., P/BV, 長期的な傾向、競合他社との比較
Eli Lilly & Co. | Abbott Laboratories | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Gilead Sciences Inc. | Illumina Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | Zoetis Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019/12/31 | 51.67 | 4.96 | — | 13.84 | 2.80 | 3.93 | 9.43 | 6.61 | 7.83 | 3.00 | 3.79 | 10.23 | 25.42 |
2018/12/31 | 12.87 | 4.38 | — | 9.41 | 5.89 | 3.89 | 11.43 | 6.08 | 7.79 | 3.80 | 5.07 | 10.68 | 18.74 |
2017/12/31 | 7.33 | 3.40 | 36.95 | 5.02 | 8.88 | 5.15 | 11.79 | 5.79 | 4.30 | 2.94 | 5.66 | 20.14 | 21.52 |
2016/12/31 | 6.33 | 3.76 | 21.24 | 4.14 | 5.66 | 4.88 | 10.95 | 4.72 | 4.51 | 3.40 | 8.58 | 18.42 | 17.46 |
2015/12/31 | 5.51 | 2.68 | 22.17 | 3.94 | 7.04 | 6.59 | 12.50 | 4.07 | 3.15 | 2.84 | 10.53 | 22.38 | 19.72 |
2014/12/31 | 5.14 | 3.32 | 56.09 | 4.59 | 6.72 | 10.08 | 19.53 | 4.01 | 3.42 | 2.95 | 16.22 | 25.60 | 17.61 |
2013/12/31 | 3.69 | 2.38 | 18.05 | 4.30 | 5.92 | 11.36 | 14.25 | 3.50 | 3.35 | 2.69 | 16.74 | 14.77 | 15.56 |
2012/12/31 | 4.15 | 2.06 | 18.06 | 3.57 | 4.40 | 7.01 | 4.58 | 3.29 | 2.44 | 2.42 | 12.91 | 10.08 | 4.15 |
2011/12/31 | 3.35 | 3.61 | — | 2.83 | 3.50 | 5.08 | 5.83 | 3.13 | 2.14 | 1.95 | 19.19 | 10.05 | — |
2010/12/31 | 3.21 | 3.24 | — | 2.04 | 2.76 | 5.29 | 7.40 | 2.88 | 1.85 | 1.75 | 6.42 | 16.16 | — |
2009/12/31 | 4.17 | 3.69 | — | 2.46 | 2.88 | 6.74 | 5.06 | 3.45 | 1.97 | 1.57 | 5.49 | 7.45 | — |
2008/12/31 | 5.01 | 4.78 | — | 2.48 | 3.29 | 9.83 | 4.59 | 3.56 | 2.72 | 1.44 | 2.94 | 21.09 | — |
2007/12/31 | 4.16 | 4.83 | — | 2.77 | 4.22 | 11.76 | 10.05 | 4.17 | 5.38 | 2.32 | 3.24 | 8.92 | — |
2006/12/31 | 5.43 | 5.88 | — | 3.96 | 5.50 | 18.07 | 8.16 | 4.78 | 5.45 | 2.49 | 5.77 | 7.52 | — |
2005/12/31 | 5.85 | 4.69 | — | 4.26 | 4.00 | 9.18 | 14.56 | 4.66 | 4.30 | 2.94 | 8.16 | 18.12 | — |
ソース: Eli Lilly & Co. (NYSE:LLY) | P/BV since 2005 (www.stock-analysis-on.net)
産業部門との比較: 医薬品とバイオテクノロジー
Eli Lilly & Co., P/BV, 長期的な傾向、産業部門との比較: 医薬品とバイオテクノロジー
Eli Lilly & Co. | 医薬品とバイオテクノロジー | |
---|---|---|
2019/12/31 | 51.67 | 6.37 |
2018/12/31 | 12.87 | 6.63 |
2017/12/31 | 7.33 | 5.52 |
2016/12/31 | 6.33 | 4.93 |
2015/12/31 | 5.51 | 4.42 |
2014/12/31 | 5.14 | 4.81 |
2013/12/31 | 3.69 | 4.11 |
2012/12/31 | 4.15 | 3.26 |
2011/12/31 | 3.35 | 2.74 |
2010/12/31 | 3.21 | 2.39 |
2009/12/31 | 4.17 | 2.56 |
2008/12/31 | 5.01 | 3.00 |
2007/12/31 | 4.16 | 3.74 |
2006/12/31 | 5.43 | 4.18 |
2005/12/31 | 5.85 | 4.09 |
ソース: Eli Lilly & Co. (NYSE:LLY) | P/BV since 2005 (www.stock-analysis-on.net)
業界との比較: 健康管理
Eli Lilly & Co., P/BV, 長期的な傾向、業界との比較: 健康管理
Eli Lilly & Co. | 健康管理 | |
---|---|---|
2019/12/31 | 51.67 | 5.44 |
2018/12/31 | 12.87 | 5.42 |
2017/12/31 | 7.33 | 4.83 |
2016/12/31 | 6.33 | 4.32 |
2015/12/31 | 5.51 | 3.85 |
2014/12/31 | 5.14 | 4.36 |
2013/12/31 | 3.69 | 3.73 |
2012/12/31 | 4.15 | 3.01 |
2011/12/31 | 3.35 | 2.59 |
2010/12/31 | 3.21 | 2.35 |
2009/12/31 | 4.17 | 2.44 |
2008/12/31 | 5.01 | 2.72 |
2007/12/31 | 4.16 | 3.53 |
2006/12/31 | 5.43 | 3.90 |
2005/12/31 | 5.85 | 4.22 |
ソース: Eli Lilly & Co. (NYSE:LLY) | P/BV since 2005 (www.stock-analysis-on.net)